DUBLIN–(BUSINESS WIRE)–The report “NRT Smoking Cessation Aids in Singapore” has been added to from ResearchAndMarkets.com offer.
When Singapore entered phase three of the country’s safe reopening in early 2021, rules on social restrictions were eased, with social gatherings allowed to resume for groups of up to eight people. Employees started returning to offices to work when the government announced that up to 75% of staff could return from April 2021.
The Publisher’s Report on NRT Smoking Cessation Aids in Singapore offers a comprehensive guide to the size and shape of the market nationwide. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. The forecasts until 2025 illustrate the evolution of the market.
NRT gum, NRT inhalers, NRT lozenges, NRT patches, other NRTs.
Market sizes (historical and forecast), company shares, brand shares and distribution data.
Why buy this report?
Obtain a detailed picture of the NRT Smoking Cessation Aids Market;
Identify promising sectors and identify factors of change;
Understand the competitive environment, major market players and leading brands;
Use five-year forecasts to assess the expected market development.
Main topics covered:
1. KEY DATA FINDINGS
2. 2021 DEVELOPMENTS
Easing of social restrictions when reopening safely to increase smoking rates
Stress, anxiety and boredom caused by the uncertainty of the pandemic
Reinforcement of anti-tobacco regulations from 2021
3. PROSPECTS AND OPPORTUNITIES
Multi-pronged approach to reduce smoking by local government
Subsidized nicotine replacement therapy to increase awareness of available support
4. TSN smoking cessation aids remain a consolidated competitive landscape
5. CATEGORY INDICATORS
6. CATEGORY DATA
7. CONSUMER HEALTH IN SINGAPORE
8. EXECUTIVE SUMMARY
Consumer Health in 2021: The Big Picture
Key trends 2021
What future for consumer health?
9. MARKET INDICATORS
10. MARKET DATA
For more information about this report visit https://www.researchandmarkets.com/r/ba16nu